Endogenous nitric oxide synthase inhibitors are responsible for the L‐arginine paradox

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107 · see citing works

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181 · see citing works

Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.

Förstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., & Kleinert, H. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.1121 · Cited by 1,115 · see citing works

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.

Creager, M. A., Gallagher, S. J., Girerd, X. J., Coleman, S. M., Dzau, V. J., & Cooke, J. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115987 · Cited by 813 · see citing works

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 801 · see citing works

Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst.

Iyengar, R., Stuehr, D. J., & Marletta, M. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6369 · Cited by 664 · see citing works

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490 · see citing works

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

Surdacki, A., Nowicki, M. P., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 422 · see citing works

Isolation and Identification of N,N- and N,N' -Dimethylarginine, Nε-Mono-, Di-, and Trimethyllysine, and Glucosylgalactosyl- and Galactosyl-δ-hydroxylysine from Human Urine

Kakimoto, Y., & Akazawa, S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62716-4 · Cited by 409 · see citing works

Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B

Closs, E. I., Basha, F. Z., Habermeier, A., & Förstermann, U. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0106 · Cited by 385 · see citing works

Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal Disease

Kielstein, J. T., Böger, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., Koch, K. M., & Frölich, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 360 · see citing works

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

Bode‐Böger, S. M., Böger, R. H., Kienke, S., Junker, W., & Frölich, J. C. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0279 · Cited by 303 · see citing works

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

Girerd, X. J., Hirsch, A. T., Cooke, J. P., Dzau, V. J., & Creager, M. A. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1301 · Cited by 268 · see citing works

Protein Methylation

Paik, W. K., & Kim, S. (1971) · Science · doi:10.1126/science.174.4005.114 · Cited by 267 · see citing works

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Creutzig, A., Alexander, K., & Frölich, J. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00375-1 · Cited by 263 · see citing works

L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationship

Bode‐Böger, S. M., Böger, R. H., Galland, A., Tsikas, D., & Frölich, J. C. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00803.x · Cited by 258 · see citing works

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production

Böger, R. H., Bode-Böger, S. M., Mügge, A., Kienke, S., Brandes, R., Dwenger, A., & Frölich, J. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05582-h · Cited by 252 · see citing works

l -Arginine Induces Nitric Oxide–Dependent Vasodilation in Patients With Critical Limb Ischemia

Bode‐Böger, S. M., Böger, R. H., Alfke, H., Heinzel, D., Tsikas, D., Creutzig, A., Alexander, K., & Frölich, J. C. (1996) · Circulation · doi:10.1161/01.cir.93.1.85 · Cited by 196 · see citing works

N-Nitro-L-arginine and N-Monomethyl-L-arginine Exhibit a Different Pattern of Inactivation Toward the Three Nitric Oxide Synthases

Reif, D. W., & Mccreedy, S. A. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1356 · Cited by 185 · see citing works

Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginine

Hecker, M., Mitchell, J. A., Harris, H. J., Katsura, M., Thiemermann, C., & Vane, J. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90627-y · Cited by 184 · see citing works

The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications

Böger, R. H., Bode‐Böger, S. M., & Frölich, J. C. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05953-9 · Cited by 168 · see citing works

L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits.

Rossitch, E., Alexander, E., Black, P. M., & Cooke, J. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115132 · Cited by 161 · see citing works

Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase

Faraci, F. M., Brian, J. E., & Heistad, D. D. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.5.h1522 · Cited by 159 · see citing works

Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation.

Klatt, P., Schmidt, K., Brünner, F., & Mayer, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42080-1 · Cited by 158 · see citing works

l -Arginine Infusion Decreases Peripheral Arterial Resistance and Inhibits Platelet Aggregation in Healthy Subjects

Bode‐Böger, S. M., Böger, R. H., Creutzig, A., Tsikas, D., Gutzki, F. M., Alexander, K. G., & Frölich, J. C. (1994) · Clinical Science · doi:10.1042/cs0870303 · Cited by 148 · see citing works

Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation

Feldman, P. L., Griffith, O. W., Hong, H., & Stuehr, D. J. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00056a009 · Cited by 127 · see citing works

l ‐ARGININE INFUSION INDUCES HYPOTENSION AND DIURESIS/NATRIURESIS WITH CONCOMITANT INCREASED URINARY EXCRETION OF NITRITE/NITRATE AND CYCLIC GMP IN HUMANS

Kanno, K., Hirata, Y., Emori, T., Ohta, K., Eguchi, S., Imai, T., & Marumo, F. (1992) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1992.tb00514.x · Cited by 125 · see citing works

Inactivation of macrophage nitric oxide synthase activity by NG-Methyl-L-arginine

Olken, N. M., Rusche, K. M., Richards, M. K., & Marletta, M. A. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91864-9 · Cited by 105 · see citing works

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemia

Masuda, H., Goto, M., Tamaoki, S., & Azuma, H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702298 · Cited by 99 · see citing works

Role of L-arginine-nitric oxide pathway in hypertension

Hishikawa, K., Nakaki, T., Suzuki, H., Katot, R., & Saruta, T. (1993) · Journal of Hypertension · doi:10.1097/00004872-199306000-00008 · Cited by 90 · see citing works

Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography–mass spectrometry

Tsikas, D., Sandmann, J., Savva, A., Lueßen, P., Böger, R. H., Gutzki, F., Mayer, B., & Frölich, J. C. (2000) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00142-0 · Cited by 85 · see citing works

Mechanistic probes of N-hydroxylation of L-arginine by the inducible nitric oxide synthase from murine macrophages

Pufahl, R. A., Nanjappan, P., Woodard, R. W., & Marletta, M. A. (1992) · Biochemistry · doi:10.1021/bi00144a024 · Cited by 79 · see citing works

Long term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats

Böger, R. H., Bode‐Böger, S. M., Gerecke, U., & Frölich, J. C. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.4.494 · Cited by 76 · see citing works

METHYLATED AMINO ACID RESIDUES OF PROTEINS OF BRAIN AND OTHER ORGANS

Kakimoto, Y., Matsuoka, Y., Miyake, M., & Konishi, H. (1975) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1975.tb03653.x · Cited by 58 · see citing works

URINARY NO3− EXCRETION AS AN INDICATOR OF NITRIC OXIDE FORMATION IN VIVO DURING ORAL ADMINISTRATION OF l ‐ARGININE OR l ‐NAME IN RATS

Böger, R. H., Bode‐Böger, S. M., Gerecke, U., Gutzki, F. M., Tsikas, D., & Frölich, J. C. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb03055.x · Cited by 57 · see citing works

L-arginine Stimulates NO-Dependent Vasodilation in Healthy Humans—Effect of Somatostatin Pretreatment

Bode‐Böger, S. M., Böger, R. H., Löffler, M., Tsikas, D., Brabant, G. E., & Frölich, J. C. (1999) · Journal of Investigative Medicine · doi:10.1177/108155899904700107 · Cited by 43 · see citing works

Isolation and Identification of Methylarginines from Bovine Brain

Kotani, K., Ueno, S., Sano, A., & Kakimoto, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09371.x · Cited by 28 · see citing works

Correspondence

(1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00482-9 · Cited by 16 · see citing works

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

Böger, R. H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00500-5 · Cited by 393 · see citing works

Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease

Kielstein, J. T., Diaeresisger, R. H. B., Bode‐Böger, S. M., Diaeresis]lich, J. D. C. F., Haller, H. G., Ritz, E., & Fliser, D. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131170 · Cited by 368 · see citing works

Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the “L-Arginine Paradox” and Acts as a Novel Cardiovascular Risk Factor

Böger, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2842s · Cited by 363 · see citing works

Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox

Lee, J.-H., Ryu, H., Ferrante, R. J., Morris, S. M., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0735876100 · Cited by 358 · see citing works

Cellular ADMA: Regulation and action

Teerlink, T., Luo, Z., Palm, F., & Wilcox, C. S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.08.002 · Cited by 344 · see citing works

Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production

Rutschman, R. L., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A., & Murray, P. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2173 · Cited by 324 · see citing works

Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans

Wu, G., Meininger, C. J., McNeal, C. J., Bazer, F. W., & Rhoads, J. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-74180-8_10 · Cited by 311 · see citing works

Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance

Cynober, L. A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00780-3 · Cited by 303 · see citing works

Nitric Oxide is Involved in the Azospirillum brasilense-induced Lateral Root Formation in Tomato

Creus, C. M., Graziano, M., Casanovas, E. M., Pereyra, M. A., Simontacchi, M., Puntarulo, S., Barassi, C. A., & Lamattina, L. (2005) · Planta · doi:10.1007/s00425-005-1523-7 · Cited by 270 · see citing works

The role of asymmetric and symmetric dimethylarginines in renal disease

Schwedhelm, E., & Böger, R. H. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.31 · Cited by 262 · see citing works

Evidence for the Pathophysiological Role of Endogenous Methylarginines in Regulation of Endothelial NO Production and Vascular Function

Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P. N., Tsai, A.-L., Berka, V., & Zweier, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603606200 · Cited by 246 · see citing works

Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X

Chen, J., Hsu, N., Wu, T.-C., Lin, S., & Chang, M.-S. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02664-4 · Cited by 229 · see citing works

Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease

Villanueva, C., & Giulivi, C. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.04.004 · Cited by 225 · see citing works

The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function

Maas, R., Schwedhelm, E., Albsmeier, J., & Böger, R. H. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm429ra · Cited by 199 · see citing works

Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study

Schulze, F., Lenzen, H., Hanefeld, C., Bartling, A., Osterziel, K. J., Goudeva, L., Schmidt‐Lucke, C., Kusus, M., Maas, R., Schwedhelm, E., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.005 · Cited by 185 · see citing works

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

LEIPER, J. M., & Nandi, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3358 · Cited by 176 · see citing works

Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?

Kielstein, J. T., & Zoccali, C. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.05.009 · Cited by 171 · see citing works

Sepsis: An arginine deficiency state?

Luiking, Y. C., Poeze, M., Dejong, C. H. C., Ramsay, G., & Deutz, N. E. P. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142939.81045.a0 · Cited by 170 · see citing works

Modulation of endothelial nitric oxide by plant-derived products

Schmitt, C. A., & Dirsch, V. M. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.05.006 · Cited by 169 · see citing works

High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma

Schwedhelm, E., Maas, R., Tan-Andresen, J., Schulze, F., Riederer, U., & Böger, R. H. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.11.052 · Cited by 168 · see citing works

RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability

Grau, M., Pauly, S., Ali, J., Walpurgis, K., Thevis, M., Bloch, W., & Suhr, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056759 · Cited by 163 · see citing works

Analysis of Citrulline, Arginine, and Methylarginines Using High‐Performance Liquid Chromatography

Wu, G., & Meininger, C. J. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)00810-5 · Cited by 147 · see citing works

Association of Asymmetric Dimethylarginine and Endothelial Dysfunction

Böger, R. H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.225 · Cited by 147 · see citing works

l -citrulline and l -arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits

Hayashi, T., Juliet, P. A. R., Matsui‐Hirai, H., Miyazaki, A., Fukatsu, A., Funami, J., Iguchi, A., & Ignarro, L. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506595102 · Cited by 143 · see citing works

Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans

Chan, J. R., Böger, R. H., Bode‐Böger, S. M., Tangphao, O., Tsao, P. S., Blaschke, T. F., & Cooke, J. P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1040 · Cited by 140 · see citing works

Vascular effects of dietary l-arginine supplementation

Preli, R. B., Klein, K. P., & Herrington, D. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00717-1 · Cited by 139 · see citing works

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover

Marliss, E. B., Chevalier, S., Gougeon, R., Morais, J. A., Lamarche, M., Adegoke, O. A. J., & Wu, G. (2005) · Diabetologia · doi:10.1007/s00125-005-0066-6 · Cited by 135 · see citing works

Endothelial dysfunction and oxidative stress in arterial hypertension

Ferroni, P., Basili, S., Paoletti, V., & Davı̀, G. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.11.012 · Cited by 131 · see citing works

Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy.

Bełtowski, J., & Kȩdra, A. (2006) · PubMed · Cited by 131 · see citing works

A critical review and discussion of analytical methods in the l-arginine/nitric oxide area of basic and clinical research

Tsikas, D. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.04.018 · Cited by 131 · see citing works

Short-term effects of l-citrulline supplementation on arterial stiffness in middle-aged men

Ochiai, M., Hayashi, T., Morita, M., Ina, K., Maeda, M., Watanabe, F., & Morishita, K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.004 · Cited by 127 · see citing works

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke

Schulze, F., Carter, A. M., Schwedhelm, E., Ajjan, R., Maas, R., von Holten, R.-A., Atzler, D., Grant, P. J., & Böger, R. H. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.039 · Cited by 124 · see citing works

Impaired l -Arginine Transport and Endothelial Function in Hypertensive and Genetically Predisposed Normotensive Subjects

Schlaich, M. P., Parnell, M. M., Ahlers, B. A., Finch, S., Marshall, T., Zhang, W., & Kaye, D. M. (2004) · Circulation · doi:10.1161/01.cir.0000149748.79945.52 · Cited by 124 · see citing works

Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Asymmetric Dimethylarginine in Human Plasma

Schwedhelm, E., Tan-Andresen, J., Maas, R., Riederer, U., Schulze, F., & Böger, R. H. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046037 · Cited by 122 · see citing works

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

Böger, R. H., & Zoccali, C. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00030-8 · Cited by 120 · see citing works

Arginine, citrulline and nitric oxide metabolism in sepsis

Kao, C. C., Bandi, V., Guntupalli, K. K., Wu, M., Castillo, L., & Jahoor, F. (2008) · Clinical Science · doi:10.1042/cs20080444 · Cited by 119 · see citing works

Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials

Böger, R. H. (2005) · Vascular Medicine · doi:10.1177/1358836x0501000104 · Cited by 120 · see citing works

Estrogen Stimulates Dimethylarginine Dimethylaminohydrolase Activity and the Metabolism of Asymmetric Dimethylarginine

Holden, D. P., Cartwright, J. E., Nussey, S., & Whitley, G. S. J. (2003) · Circulation · doi:10.1161/01.cir.0000091083.61609.df · Cited by 117 · see citing works

The Clinical Significance of Asymmetric Dimethylarginine

Siroen, M. P. C., Teerlink, T., Nijveldt, R. J., Prins, H. A., Richir, M. C., & van Leeuwen, P. A. M. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111320 · Cited by 115 · see citing works

Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus

Anderssohn, M., Schwedhelm, E., Lüneburg, N., Vasan, R. S., & Böger, R. H. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110366053 · Cited by 114 · see citing works

Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)

Maas, R. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm605oa · Cited by 112 · see citing works

Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease

Nkuipou‐Kenfack, E., Duranton, F., Gayrard, N., Argilés, À., Lundin, U., Weinberger, K. M., Dakna, M., Delles, C., Mullen, W., Husi, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096955 · Cited by 108 · see citing works

AMINO ACIDS, ARGINASE AND NITRIC OXIDE IN VASCULAR HEALTH

Huynh, N., & Chin-Dusting, J. P. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04316.x · Cited by 107 · see citing works

Dimethylarginine Dimethylaminohydrolase Overexpression Enhances Insulin Sensitivity

Sydow, K., Mondon, C. E., Schrader, J., Konishi, H., & Cooke, J. P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.162073 · Cited by 102 · see citing works

Biochemical responses of healthy subjects during dietary supplementation with L-arginine

Evans, R. W., Fernstrom, J. D., Thompson, J., Morris, S. M., & Kuller, L. H. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.03.005 · Cited by 97 · see citing works

The human liver clears both asymmetric and symmetric dimethylarginine†

Siroen, M. P. C., van der Sijp, J. R. M., Teerlink, T., van Schaik, C., Nijveldt, R. J., & van Leeuwen, P. A. M. (2005) · Hepatology · doi:10.1002/hep.20579 · Cited by 97 · see citing works

Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase

Böger, R. H., Vallance, P. J., & Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00027-8 · Cited by 96 · see citing works

Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography–mass spectrometry as pentafluorobenzamide derivative: Evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease

Tsikas, D., Thum, T., Becker, T., Pham, V. V., Chobanyan-Jürgens, K., Mitschke, A., Beckmann, B., Gutzki, F., Bauersachs, J. K., & Stichtenoth, D. O. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.015 · Cited by 95 · see citing works

Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events

Krempl, T. K., Maas, R., Sydow, K., Meinertz, T., Böger, R. H., & Kahler, J. P. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi287 · Cited by 93 · see citing works

Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism

Royo, F., Moreno, L., Mleczko, J., Palomo, L., González, E., Cabrera, D., Cogolludo, A. L., Pérez‐Vizcaíno, F., Liempd, S. M. V., & Falcón‐Pérez, J. M. (2017) · Scientific Reports · doi:10.1038/srep42798 · Cited by 88 · see citing works

Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease

Caplin, B., & LEIPER, J. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.247726 · Cited by 87 · see citing works

Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells

Joshi, M. S., Ferguson, T. B., Johnson, F. K., Johnson, R. A., Parthasarathy, S., & Lancaster, J. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506824104 · Cited by 85 · see citing works

Homoarginine in the renal and cardiovascular systems

Pilz, S., Meinitzer, A., Gaksch, M., Grübler, M. R., Verheyen, N., Drechsler, C., Hartaigh, B. Ó., Lang, F. J. W., Alesutan, I., Voelkl, J. G. J., et al. (2015) · Amino Acids · doi:10.1007/s00726-015-1993-2 · Cited by 77 · see citing works

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects

Alvares, T., Conte-Junior, C., Silva, J., & Paschoalin, V. M. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-54 · Cited by 76 · see citing works

The electrochemical and fluorescence detection of nitric oxide in the cochlea and its increase following loud sound

Shi, X., Ren, T., & Nuttall, A. L. (2002) · Hearing Research · doi:10.1016/s0378-5955(01)00409-9 · Cited by 74 · see citing works

Parenteral or Enteral Arginine Supplementation Safety and Efficacy

Rosenthal, M. D., Carrott, P. W., Patel, J. J., Kiraly, L. N., & Martindale, R. G. (2016) · Journal of Nutrition · doi:10.3945/jn.115.228544 · Cited by 73 · see citing works

Quantifying the l-arginine paradox in vivo

Vukosavljevic, N., Jaron, D., Barbee, K. A., & Buerk, D. G. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.10.006 · Cited by 70 · see citing works

A review and discussion of platelet nitric oxide and nitric oxide synthase: do blood platelets produce nitric oxide from l-arginine or nitrite?

Gambaryan, S. P., & Tsikas, D. (2015) · Amino Acids · doi:10.1007/s00726-015-1986-1 · Cited by 67 · see citing works

Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks’ gestation and preeclampsia: a case–control study

Khalil, A. A., Tsikas, D., Akolekar, R., Jordan, J., & Nicolaides, K. H. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.109 · Cited by 68 · see citing works

Antioxidants and endothelial dysfunction in Hyperlipidemia

Warnholtz, A., Mollnau, H., Oelze, M., Wendt, M., & Münzel, T. F. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0081-z · Cited by 67 · see citing works

The role of arginine, homoarginine and nitric oxide in pregnancy

Khalil, A. A., Hardman, L., & O’Brien, P. (2015) · Amino Acids · doi:10.1007/s00726-015-2014-1 · Cited by 65 · see citing works

Importance of integrin β1-mediated cell adhesion on biodegradable polymers under serum depletion in mesenchymal stem cells and chondrocytes

Lee, J. W., Kim, Y. H., Park, K. D., Jee, K. S., Shin, J. W., & Hahn, S. B. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.037 · Cited by 66 · see citing works

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA

Smith, C. L., Anthony, S., Hubank, M. J. F., LEIPER, J. M., & Vallance, P. J. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020264 · Cited by 66 · see citing works

Endogenous Methylarginines Regulate Neuronal Nitric-oxide Synthase and Prevent Excitotoxic Injury

Cardounel, A. J., & Zweier, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108983200 · Cited by 66 · see citing works

Effects of L-arginine supplementation on exercise metabolism

McConell, G. K. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32801162fa · Cited by 64 · see citing works

Development and validation of GC–MS methods for the comprehensive analysis of amino acids in plasma and urine and applications to the HELLP syndrome and pediatric kidney transplantation: evidence of altered methylation, transamidination, and arginase activity

Hanff, E., Ruben, S., Kreuzer, M., Bollenbach, A., Kayacelebi, A. A., Das, A. M., von Versen‐Höynck, F., von Kaisenberg, C., Haffner, D., Ückert, S., et al. (2019) · Amino Acids · doi:10.1007/s00726-018-02688-w · Cited by 63 · see citing works

Acute effects of various fast-food meals on vascular function and cardiovascular disease risk markers: the Hamburg Burger Trial

Rudolph, T. K., Ruempler, K., Schwedhelm, E., Tan-Andresen, J., Riederer, U., Böger, R. H., & Maas, R. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.334 · Cited by 63 · see citing works

Asymmetric dimethylarginine (ADMA)—A modulator of nociception in opiate tolerance and addiction?

Kielstein, A., Tsikas, D., Galloway, G. P., & Mendelson, J. E. (2007) · Nitric Oxide · doi:10.1016/j.niox.2007.05.005 · Cited by 62 · see citing works

Safety of long-term dietary supplementation with l-arginine in rats

Yang, Y., Wu, Z., Jia, S., DAHANAYAKA, S. A., Feng, S., Meininger, C. J., McNeal, C. J., & Wu, G. (2015) · Amino Acids · doi:10.1007/s00726-015-1992-3 · Cited by 61 · see citing works

Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age

Lücke, T., Kanzelmeyer, N. K., Kemper, M. J., Tsikas, D., & Das, A. M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.300 · Cited by 57 · see citing works

A Novel Lipid Hydroperoxide-Derived Modification to Arginine

Oe, T., Lee, S. H., Elipe, M. V. S., Arison, B. H., & Blair, I. A. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034178l · Cited by 56 · see citing works

Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia

Masuda, H., Tsujii, T., Okuno, T., Kihara, K., Goto, M., & Azuma, H. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00277.2001 · Cited by 56 · see citing works

Glycemic Control Modulates Arginine and Asymmetrical-Dimethylarginine Levels during Critical Illness by Preserving Dimethylarginine-Dimethylaminohydrolase Activity

Ellger, B., Richir, M. C., van Leeuwen, P. A. M., Debaveye, Y. A., Langouche, L., Vanhorebeek, I., Teerlink, T., & den Berghe, G. V. (2008) · Endocrinology · doi:10.1210/en.2007-1558 · Cited by 55 · see citing works

Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease

Παπαγεωργίου, Ν., Androulakis, E. S., Papaioannou, S., Antoniades, C. A., & Tousoulis, D. (2015) · Amino Acids · doi:10.1007/s00726-015-2017-y · Cited by 54 · see citing works

Elevated Homocysteine and Asymmetric Dimethyl Arginine Levels in Pulmonary Hypertension Associated With Congenital Heart Disease

Şanlı, C., Oğuz, D., Olguntürk, R., Tunaoglu, F. S., Kula, S., Paşaoğlu, H., Gülbahar, Ö., & Çevik, A. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0321-9 · Cited by 54 · see citing works

Structural and Functional Characterization of the Zn(II) Site in Dimethylargininase-1 (DDAH-1) from Bovine Brain

Knipp, M., Charnock, J., Garner, C. D., & Vašák, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104056200 · Cited by 52 · see citing works

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)

Strobel, J., Müller, F., Zolk, O., Endreß, B., König, J., Fromm, M. F., & Maas, R. (2013) · Amino Acids · doi:10.1007/s00726-013-1556-3 · Cited by 51 · see citing works

Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine–nitric oxide metabolic system in humans

Mariotti, F., Petzke, K. J., Bonnet, D., Szézépanski, I., Bos, C., Huneau, J., & Fouillet, H. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.048025 · Cited by 50 · see citing works

Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects

Paroni, R. C., Fermo, I., Fiorina, P., & Cighetti, G. (2005) · Amino Acids · doi:10.1007/s00726-005-0191-z · Cited by 48 · see citing works

Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?

Zoccali, C., & Kielstein, J. T. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000222701.22583.e8 · Cited by 47 · see citing works

Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free l-arginine in humans

Kayacelebi, A. A., Langen, J., Weigt-Usinger, K., Chobanyan-Jürgens, K., Mariotti, F., Schneider, J. Y., Rothmann, S., Frölich, J. C., Atzler, D., Choe, C., et al. (2015) · Amino Acids · doi:10.1007/s00726-015-2012-3 · Cited by 47 · see citing works

Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs

Rajasekaran, K., Rajadas, J., & Venkatachalam, K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02878-6 · Cited by 47 · see citing works

Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction

Masuda, H. (2008) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01973.x · Cited by 45 · see citing works

Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update

Poyton, R., & Hendrickson, M. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58280 · Cited by 45 · see citing works

Candidate serum metabolite biomarkers of residual feed intake and carcass merit in sheep

Goldansaz, S. A., Markus, S. B., Berjanskii, M. V., Rout, M. K., Guo, A. C., Wang, Z., Plastow, G. S., & Wishart, D. S. (2020) · Journal of Animal Science · doi:10.1093/jas/skaa298 · Cited by 43 · see citing works

Two Hypomorphic Alleles of Mouse Ass1 as a New Animal Model of Citrullinemia Type I and Other Hyperammonemic Syndromes

Pérez, C. J., Jaubert, J., Guénet, J., Barnhart, K. F., Ross‐Inta, C., Quintanilla, V. C., Aubin, I., Brandon, J. L., Otto, N., DiGiovanni, J., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100118 · Cited by 43 · see citing works

Role of Asymmetrical Dimethylarginine in Renal Microvascular Endothelial Dysfunction in Chronic Renal Failure with Hypertension

Okubo, K., Hayashi, K., Wakino, S., Matsuda, H., KUBOTA, E., Honda, M., Tokuyama, H., Yamamoto, T., Kajiya, F., & Saruta, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.181 · Cited by 42 · see citing works

UVA irradiation induces L-isoaspartyl formation in melanoma cell proteins.

D'Angelo, S., Ingrosso, D., Perfetto, B., Baroni, A., Zappia, M., Lobianco, L., Tufano, M., & Galletti, P. (2001) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(01)00518-4 · Cited by 40 · see citing works

Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study

van der Zwan, L. P., Scheffer, P. G., Dekker, J. M., Stehouwer, C. D. A., Heine, R. J., & Teerlink, T. (2011) · Clinical Science · doi:10.1042/cs20100595 · Cited by 40 · see citing works

Accurate quantification of dimethylamine (DMA) in human plasma and serum by GC–MS and GC–tandem MS as pentafluorobenzamide derivative in the positive-ion chemical ionization mode

Chobanyan-Jürgens, K., Mitschke, A., Gutzki, F., Stichtenoth, D. O., & Tsikas, D. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.03.006 · Cited by 40 · see citing works

The Prominent Role of the Liver in the Elimination of Asymmetric Dimethylarginine (ADMA) and the Consequences of Impaired Hepatic Function

Richir, M. C., Bouwman, R. H., Teerlink, T., Siroen, M. P. C., de Vries, T. P. G. M., & van Leeuwen, P. A. M. (2008) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607108321702 · Cited by 39 · see citing works

Quantitative Analysis of l-Arginine, Dimethylated Arginine Derivatives, l-Citrulline, and Dimethylamine in Human Serum Using Liquid Chromatography–Mass Spectrometric Method

Fleszar, M. G., Wiśniewski, J. Ł., Krzystek‐Korpacka, M., Misiak, B., Frydecka, D., Piechowicz, J., Lorenc-Kukuła, K., & Gamian, A. (2018) · Chromatographia · doi:10.1007/s10337-018-3520-6 · Cited by 40 · see citing works

Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders

Gawryś, J., Gajecki, D., Szahidewicz-Krupska, E., & Doroszko, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1015908 · Cited by 40 · see citing works

Nitric Oxide Signaling in the Microcirculation

Buerk, D. G., Barbee, K. A., & Jaron, D. (2011) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v39.i5.40 · Cited by 39 · see citing works

L-Arginine and Asymmetric Dimethylarginine Are Early Predictors for Survival in Septic Patients with Acute Liver Failure

Brenner, T., Fleming, T. H., Rosenhagen, C., Krauser, U., Mieth, M., Bruckner, T. M., Martin, E., Nawroth, P. P., Weigand, M. A., Bierhaus, A., et al. (2012) · Mediators of Inflammation · doi:10.1155/2012/210454 · Cited by 39 · see citing works

Regulation of L-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells

Durante, W. (2001) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:35:1:19 · Cited by 39 · see citing works

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine

Greco, R., Ferrigno, A., Demartini, C., Zanaboni, A., Mangione, A. S., Blandini, F., Nappi, G., Vairetti, M., & Tassorelli, C. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0560-2 · Cited by 38 · see citing works

Urea Transporter UT-B Deletion Induces DNA Damage and Apoptosis in Mouse Bladder Urothelium

Dong, Z., Ran, J., Zhou, H., Chen, J., Lei, T., Wang, W., Sun, Y. X., Lin, G., Bankir, L., & Yang, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076952 · Cited by 36 · see citing works

Effects of chronic oral l-arginine administration on the l-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: l-Arginine prevents renal loss of nitrite, the major NO reservoir

Schneider, J. Y., Rothmann, S., Schröder, F., Langen, J., Lücke, T., Mariotti, F., Huneau, J., Frölich, J. C., & Tsikas, D. (2015) · Amino Acids · doi:10.1007/s00726-015-2031-0 · Cited by 36 · see citing works

The arginine paradox.

Nakaki, T., & Hishikawa, K. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.7 · Cited by 15 · see citing works

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

Leiper, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00162-5 · Cited by 458 · see citing works

Effects of Arginase I and II on the local production of NO

Elms, S. C., Morris, S. M., Caldwell, W., & Fulton, D. (2009) · The FASEB Journal · doi:10.1096/fasebj.23.1_supplement.628.5

Inhibition of nitric oxide synthase by l -arginine metabolites

Das, I., & Khan, N. (1995) · Biochemical Society Transactions · doi:10.1042/bst023324s · Cited by 4 · see citing works

To Give or Not to Give? Lessons from the Arginine Paradox

Dioguardi, F. S. (2011) · Lifestyle Genomics · doi:10.1159/000327777 · Cited by 90 · see citing works